💊 Pharma News Update

The US FDA approves monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug, marking a significant step forward in neurodegenerative care.

#PharmaNews #FDAApproval #AlzheimersTreatment #NeurologyInnovation #2025WCAC